 |
市場調査レポート
商品コード
942630
ゲノム編集・ゲノムエンジニアリングの世界市場 (～2025年)：CRISPR・TALEN・ZFN・アンチセンスGenome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User & Region-Global Forecast to 2025 |
||||||
| ゲノム編集・ゲノムエンジニアリングの世界市場 (～2025年)：CRISPR・TALEN・ZFN・アンチセンス |
|
出版日: 2020年06月09日
発行: MarketsandMarkets
ページ情報: 英文 148 Pages
納期: 即納可能
 |
世界のゲノム編集・ゲノムエンジニアリングの市場は予測期間中17.0％のCAGRで推移し、2020年の51億米ドルから、2025年には112億米ドルの規模に成長すると予測されています。政府資金の投入拡大、ゲノミクスプロジェクト件数の増加、感染症および癌の有病率の高さ、技術的進歩、GM作物の生産量の増加、ゲノミクスの応用分野の拡大などの要因が同市場の成長を推進しています。しかし一方で、ゲノム機器の高コスト性が市場のさらなる成長の妨げとなっています。技術別で見ると、技術の扱いやすさやマルチプレックス機能から、CRISPR部門が2019年の最大のシェアを獲得しました。またエンドユーザー別では、製薬会社が同年、最大のシェアを獲得しました。同部門の成長は、感染症や癌の有病率の増加から、医薬品開発が活発化していることに起因しています。さらに地域別では、アジア太平洋地域が予測期間中、最大のCAGRを示すと予測されています。同地域の製薬・バイオ医薬品業界の急速な成長、ゲノムプロジェクトの増加、遺伝的に多様な人口の存在などの要因が、同地域の高い成長率を支えています。
当レポートでは、世界のゲノム編集・ゲノムエンジニアリングの市場を調査し、市場の定義と概要、バリューチェーン、市場成長への各種影響因子の分析、市場規模の推移・予測、技術・用途・製品&サービス区分・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業プロファイルなどをまとめています。
"Rising government funding and increase in the number of genomic projects, especially in the area of rare diseases, and a growing application horizon are all expected to drive the growth of the genome editing/genome engineering market."
The global genome editing/genome engineering market is projected to reach USD 11.2 billion in 2025 from USD 5.1 billion in 2020, at a CAGR of 17.0 % during the forecast period. Market growth is largely driven by factors such as the rise in government funding, growth in the number of genomics projects, high prevalence of infectious diseases & cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. However, the high cost of genomic equipment will restrain the growth of this market.
Based on technology, the market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies. CRISPR accounted for the largest share of the genome editing/genome engineering market in 2019. The large share of this segment can be attributed to the ease of use associated with the CRISPR technology and its ability to multiplex.
By end user, the genome editing/genome engineering market is segmented into pharmaceutical companies, biotechnology companies, and academic & government research institutes. The pharmaceutical companies segment accounted for the largest share of the market. The pharmaceutical companies segment accounted for the largest share of the genome editing/genome engineering market in 2019. This is due to the increasing prevalence of infectious diseases and cancer, which is driving research in the pharma sector for drug development.
The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Factors such as the rapid growth in the pharmaceutical and biopharmaceutical industry, the rising number of genomic projects, and the presence of a genetically diverse population have supported the region's high growth rate.
In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, other directors, and executives from various key organizations operating in the genome editing/genome engineering market.
The major companies in the genome editing/genome engineering market include Thermo Fisher Scientific (US), Merck (Germany), Horizon Discovery Limited (UK), Lonza (Switzerland), GenScript (US), Eurofins Scientific (Luxembourg), and Sangamo Therapeutics (US).
The study includes an in-depth competitive analysis of these key players in the genome editing/genome engineering market, along with their company profiles, recent developments, and key market strategies.
The market study covers the genome editing/genome engineering market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, such as products, technology, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall genome editing/genome engineering market and its subsegments. This report will help stakeholders to understand the competitive landscape, gain insights to better position their businesses, and plan suitable go-to-market strategies. The report will also help stakeholders to understand the pulse of the market and provide information on the key market drivers, restraints, opportunities, and challenges.
*Business overview, Products and Services offered, Recent developments, MNM view might not be captured in case of unlisted companies.
比較リスト
